259 related articles for article (PubMed ID: 29297952)
1. First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy.
Cheng Y; Xu Z; Zhang Y; Wu J; Wang F; Mo X; Chen Y; Han W; Jia J; Wang Y; Zhang X; Huang X; Zhang L; Xu L
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29297952
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
Front Immunol; 2022; 13():837335. PubMed ID: 35178053
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
[TBL] [Abstract][Full Text] [Related]
4. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
Xu LP; Jin S; Wang SQ; Xia LH; Bai H; Gao SJ; Liu QF; Wang JM; Wang X; Jiang M; Zhang X; Wu DP; Huang XJ
J Hematol Oncol; 2017 Jan; 10(1):25. PubMed ID: 28107815
[TBL] [Abstract][Full Text] [Related]
5. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
6. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J
Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia.
Xu ZL; Zhou M; Jia JS; Mo WJ; Zhang XH; Zhang YP; Wang Y; Li YM; Huang XJ; Wang SQ; Xu LP
Bone Marrow Transplant; 2019 Aug; 54(8):1319-1326. PubMed ID: 30670825
[TBL] [Abstract][Full Text] [Related]
8. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation.
Szpecht D; Gorczyńska E; Kałwak K; Owoc-Lempach J; Choma M; Styczyński J; Goździk J; Dłużniewska A; Wysocki M; Kowalczyk JR; Chybicka A; Pieczonka A; Wachowiak J
Arch Immunol Ther Exp (Warsz); 2012 Jun; 60(3):225-33. PubMed ID: 22527354
[TBL] [Abstract][Full Text] [Related]
9. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
Geng C; Liu X; Chen M; Yang C; Han B
Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
[TBL] [Abstract][Full Text] [Related]
10. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
[TBL] [Abstract][Full Text] [Related]
11. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Multicenter Study.
Li Y; Duan F; Xiao H; Wu X; Wang S; Xu D; Liu Q; Fan Z; Nie D; Lai Y; Wu B; Lin D; Du X; Weng J; Jiang Z; Pang Y; Ouyang L; Liu Z; Zhang L; Han N; Chen L; Xiao Y
Transplantation; 2018 Oct; 102(10):1724-1731. PubMed ID: 29677078
[TBL] [Abstract][Full Text] [Related]
13. Current insights into the treatments of severe aplastic anemia in China.
Ye L; Zhang F; Kojima S
Int J Hematol; 2020 Sep; 112(3):292-299. PubMed ID: 32748215
[TBL] [Abstract][Full Text] [Related]
14. Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia.
Liu L; Zhang Y; Jiao W; Zhou H; Wang Q; Jin S; Cai Y; Zhao L; Shangguan X; Liu Z; Xu J; Lei M; Yan X; Miao M; Wu D
Leukemia; 2020 Dec; 34(12):3359-3369. PubMed ID: 32591644
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].
Zhou J; Fu YW; Liang LJ; Wang Q; Han LJ; Zu YL; Zhang Y; Zhu XH; Yu FK; Fang BJ; Wei XD; Song YP
Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):927-931. PubMed ID: 27916046
[No Abstract] [Full Text] [Related]
16. Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis-associated aplastic anemia.
Zhang X; Yang W; Yang D; Wei J; Zhang P; Feng S; Jiang E; Zhang L; He Y; Zhang F; Han M
Front Immunol; 2023; 14():1146997. PubMed ID: 37006284
[TBL] [Abstract][Full Text] [Related]
17. Unmanipulated haploidentical haematopoietic stem cell transplantation for children with severe aplastic anaemia.
Zhu H; Luo RM; Luan Z; Lee V; Zhu YP; Luo CJ; Tang XF; Si YJ; Chen J
Br J Haematol; 2016 Sep; 174(5):799-805. PubMed ID: 27263533
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor.
Choi YB; Yi ES; Lee JW; Sung KW; Koo HH; Yoo KH
Bone Marrow Transplant; 2017 Jan; 52(1):47-52. PubMed ID: 27668766
[TBL] [Abstract][Full Text] [Related]
19. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
20. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
Wang Z-; Yu H-; Cao F-; Liu Z-; Liu Z-; Feng W-; Liu X-; Yu Y-; Xiao Y; Li L-; Zhou J
Ann Hematol; 2019 Feb; 98(2):473-479. PubMed ID: 30341538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
